LINCOLN- bacitracin zinc neomycin sulfate polymyxin b sulfate ointment

Lincoln by

Drug Labeling and Warnings

Lincoln by is a Otc medication manufactured, distributed, or labeled by Lincoln Pharmaceutical Ltd.. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

Drug Facts

Bacitracin Zinc 400 units- Neomycin Sulfate 5 mg (Equivalent to 3.5 mg Neomycin) Polymyxin B sulfate 5000 units

Drug Facts

First Aid antibiotic

Drug Facts

Uses

• First aid to prevent infection in
• minor cuts
• scrapes
• burns

Drug Facts

For External use only

Drug Facts

• in the eyes
• if you are allergenic to any of the ingredients
• over the large areas of the body
• longer than 1 week unless directed by a doctor

Drug Facts

• deep or puncture wounds
• animal bites
• serious burns

Drug Facts

• the condition persists or get worse
• a rash or other allergic reaction develops

Drug Facts

If swallowed, get medical help or contact a Poison Control Center right away.

Drug Facts

• clean the affected area
• apply a small amount of this product (an amount equal to the surface area of the tip of a finger) on the area 1 to 3 times daily
• may be covered with sterile bandage

OTHER SAFETY INFORMATION

• store at room temperature 15- 30° C (59-86F)
• avoid excessive heat and humidity

Drug Facts

white petrolatum

PRINCIPAL DISPLAY PANEL

INGREDIENTS AND APPEARANCE

LINCOLN 
bacitracin zinc neomycin sulfate polymyxin b sulfate ointment

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 69636-3025
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
POLYMYXIN B SULFATE (UNII: 19371312D4) (POLYMYXIN B - UNII:J2VZ07J96K)	POLYMYXIN B	5000 [USP'U]  in 1 g
NEOMYCIN SULFATE (UNII: 057Y626693) (NEOMYCIN - UNII:I16QD7X297)	NEOMYCIN	3.5 mg  in 1 g
BACITRACIN ZINC (UNII: 89Y4M234ES) (BACITRACIN - UNII:58H6RWO52I)	BACITRACIN	400 [USP'U]  in 1 g

Inactive Ingredients
Ingredient Name	Strength
PETROLATUM (UNII: 4T6H12BN9U)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 69636-3025-2	0.5 g in 1 PACKET; Type 0: Not a Combination Product	05/17/2013
2	NDC: 69636-3025-3	0.9 g in 1 PACKET; Type 0: Not a Combination Product	05/17/2013
3	NDC: 69636-3025-5	28.3 g in 1 TUBE; Type 0: Not a Combination Product	05/17/2013
4	NDC: 69636-3025-4	14 g in 1 TUBE; Type 0: Not a Combination Product	05/17/2013

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC monograph final	part333B	05/17/2013

Labeler - Lincoln Pharmaceutical Ltd. (915839373)